Cipla Ltd
The live share price of Cipla Ltd (CIPLA) as on 31 May 4:02am is ₹960.75 from NSE/BSE.
CIPLA NSE
₹960.75 ▲0.09% (0.9)
As on May 31, 2023 09:32 AM IST
Key Metrics
PE Ratio
27.52
PB Ratio
3.66
Dividend Yield
0.89%
Sector PB
4.49
Sector PE
33.72
Sector Div Yld
0.82%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Largecap, ₹77,190 Cr
Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.
The following charts display the financial performance of the Cipla Ltd (CIPLA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Cipla Ltd (CIPLA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Largecap, ₹77,190 Cr
Financials
Income Statement
| (INR) | Y/Y Change | |
| Revenue | 23,228 Cr | +5.37% |
| Operating Expense | 17,908 Cr | +1431.04% |
| Net Income | 2,804 Cr | +11.43% |
| Net Profit Margin | 12.07% | +5.69% |
| Earning Per Share | 34 | +11.28% |
| EBITDA | 5,320 Cr | +14.37% |
Balance sheet
| (INR) | Y/Y Change | |
| Cash & short-term Inv | 4,123 Cr | +11.82% |
| Total Assets | 26,857 Cr | +8.05% |
| Total Liabilities | 5,739 Cr | -8.45% |
| Total Equity | 21,117 Cr | +13.62% |
| Shares Outstanding | 80.68 Cr | +0.04% |
| Price to Book | 3.88 | +9.27% |
| Return on Assets | 9.73% | -2.31% |
| Return on Capital | 17.05 Cr | -8.19% |
Cash Flows
| (INR) | Y/Y Change | |
| Net Income | 2,804 Cr | +11.43% |
| Cash from Operations | 3,325 Cr | -11.43% |
| Cash from Investing | -1,858 Cr | -21.73% |
| Cash from Financing | -1,599 Cr | +29.07% |
| Net Change in Cash | -132 Cr | -193.64% |
| Free Cash Flow | 2,624 Cr | -10.61% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
27.27
1Y Return
▲8.03%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
16.8
1Y Return
▲3.4%
TORNTPHARM
Torrent Pharmaceuticals Ltd
PE Ratio
69.48
1Y Return
▲18.78%
MANKIND
Mankind Pharma Ltd
PE Ratio
0
1Y Return
▼-4.67%
Latest News
Cipla vows to crack diabetes segment with licensed branded portfolio
6 days ago on Economic Times
Change since news ▼-0.99%
“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and global CEO of Cipla in an interview to ET.
Hold Cipla; target of Rs 1030: Sharekhan
6 days ago on Moneycontrol
Change since news ▼-2.43%
Sharekhan recommended Hold rating on Cipla with a target price of Rs 1030 in its research report dated May 23, 2023.
Buy Cipla; target of Rs 1167: KR Choksey
2 weeks ago on Moneycontrol
Change since news ▼-4.19%
KR Choksey is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1167 in its research report dated May 17, 2023.
FAQs on Cipla Ltd
How to buy Cipla Ltd stocks?
You can easily buy the stocks/shares of Cipla Ltd (CIPLA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Cipla Ltd?
The stock price of Cipla Ltd as on 31 May 2023 is ₹960.75
What is the 52-week High and Low of Cipla Ltd?
The 52-week high and low of Cipla Ltd (CIPLA) is ₹1,185.25 and ₹852.
What is the PE and PB ratio of Cipla Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Cipla Ltd are 27.52 and 3.66 respectively.
What are the peers or stocks similar to Cipla Ltd?
The peers or stocks similar to Cipla Ltd are Sun Pharmaceutical Industries Ltd, Dr Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Cipla Ltd belong to?
Cipla Ltd (CIPLA) belongs to the Pharmaceuticals sector.
What is the Market Cap of Cipla Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cipla Ltd (CIPLA) is ₹77,190 Cr as of 31 May 2023
Can't decide whether or not to buy Cipla Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.
smallcase Technologies Private Limited
#51, 3rd Floor, Le Parc Richmonde,
Richmond Road, Shanthala Nagar,
Richmond Town, Bangalore - 560025